Mild_vs_Severe

Mild vs Severe

p-value ≤ 0.05 6 significant 2025-09-26 00:00:00 Study: MTBLS6844
135 Total Features
6 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS6844_0001_00000002
Linked study
MTBLS6844 — Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
Comparison
Mild vs Severe
Group A
Samples from COVID-19 patients with mild symptoms.. Understanding the lipidomic profile of mild cases can help identify early markers of disease progression.
Group B
Samples from COVID-19 patients with severe symptoms.. Understanding the lipidomic profile of severe cases can help identify critical markers of disease progression and potential therapeutic targets.
Total features tested
135
Significant features
6
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
AXCLECQLCBWNLZ-KZZBVOOISA-N up 1.653 0.000373
NDBJGSQZPQASQC-DTFBBOEISA-N down 0.5377 0.00805
ZJVVOYPTFQEGPH-AUTSUKAISA-N Ceramide (d18:1/24:0) up 1.583 0.00311
QEDPUVGSSDPBMD-XTAIVQBESA-N C24 Sphingomyelin up 1.569 0.00507
VODZWWMEJITOND-NXCSZAMKSA-N <em>N</em>-stearoylsphingosine down 0.6517 0.00832
YJEMDFYSDGNQNM-NDUZERMISA-N DG(36:4) up 1.637 0.035